CRISPR-Cas System in Translational Biotechnology 1st Edition

CRISPR-Cas System in Translational Biotechnology, 1st Edition by Swati Joshi, Digvijay Verma and Ravi Kr. Gupta is an indispensable guide for scientists, clinicians and biotech professionals pursuing real-world applications of genome engineering. This clear, contemporary volume spotlights CRISPR technologies and their translational potential across therapeutics, diagnostics and agricultural biotech.

Discover concise, research-driven explanations of CRISPR-Cas mechanisms, delivery strategies, safety considerations and regulatory pathways—presented with practical insight for moving discoveries from bench to bedside or field. The authors bridge molecular detail with case studies and application-focused perspectives, making complex gene-editing concepts accessible to both early-career researchers and experienced practitioners.

Why this book matters: whether you are developing gene therapies, precision breeding programs, or molecular diagnostic tools, this edition synthesizes current advances in CRISPR systems, off-target mitigation, ethical and biosafety frameworks, and commercial translation. Emphasizing translational biotechnology, it helps teams in industry, academia and clinical settings accelerate innovation while navigating compliance and clinical trial design.

Ideal for researchers in India and globally, biotech entrepreneurs, regulatory specialists and postgraduate students, this 1st Edition equips readers with actionable knowledge to design experiments, evaluate therapeutic risk-benefit, and communicate findings to stakeholders.

Secure your copy today and stay at the forefront of genome editing. Learn how the CRISPR-Cas revolution is being translated into real-world solutions—with expert authorship, practical focus and a global outlook to support your next breakthrough.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.